Yıl: 2021 Cilt: 27 Sayı: 2 Sayfa Aralığı: 102 - 110 Metin Dili: İngilizce DOI: 10.4274/tnd.2021.53503 İndeks Tarihi: 19-01-2022

Use of Oral Nutritional Supplements in Neurology: General Principles, Special Practices

Öz:
There is convincing scientific evidence that the use of oral nutritional supplements (ONS) is advantageous in patients with disabling neurologic diseases such as stroke, dementia, amyotrophic lateral sclerosis, multiple sclerosis or Parkinson’s disease, and also in older patients with a diagnosis of malnutrition or just risk of malnutrition, and in all these cases accompanied with insufficient oral food intake or during a condition such as infection, trauma or hospitalization that may pose an increased malnutrition risk along. A wide spectrum of commercial formulas ensuring adequate patient adaptation and toleration are available. For ONS supply to be beneficial, a person at risk of malnutrition or with the diagnosis of malnutrition should consume ONS containing at least 400 kcal of energy and 30 grams of protein per day for a minimum of 1 month. ONS should not reduce the amount of normal daily food intake. If useful, ONS should be continued within the scope of predetermined goals. Supplementation of ONS is an economical and useful neurology practice.
Anahtar Kelime:

Nörolojide Oral Nütrisyonel Supleman Kullanımı: Genel İlkeler, Özel Pratikler

Öz:
Yaşlı bireylerde ve inme, demans, amiyotrofik lateral skleroz, multipl skleroz veya Parkinson hastalığı gibi nörolojik hastalığı olanlarda malnütrisyon tanısı veya riski varsa ya da malnütrisyon riski oluşturabilecek enfeksiyon, travma veya hastane yatışı gibi hallerde oral gıda alımı yetersizliği başladığında oral nütrisyonel supleman (ONS) kullanımının gündeme gelmesi gerektiği konusunda ikna edici bilimsel veri bulunmaktadır. Hastanın yeterli uyunç ve toleransını sağlayabilecek çok çeşitli ticari formül spektrumu vardır. ONS takviyesinin yararlı olabilmesi için malnütrisyon veya malnütrisyon riski olan kişide günde en az 400 kcal enerji ve 30 gram protein içeren formülün minimum 1 ay süre ile uygulanması gerekir. ONS tüketilen normal gıda miktarını azaltmamalıdır. Faydalı ise hedefler çerçevesinde devam edilmelidir. ONS takviyesi ekonomik ve faydalı bir nöroloji pratiğidir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Burgos R, Breton I, Cereda E, et al. ESPEN guideline clinical nutrition in neurology. Clin Nutr 2018;37:354-396.
  • 2. Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition. Clinical guideline [CG32]. Available from: http:// www.nnng.org.uk/2017/07/update-on-nice-guideline-on-cg32-nutritionsupport- for-adults/
  • 3. MUST Online Calculator - Malnutrition Universal Screening Tool of British Association for Parenteral and Enteral Nutrition. Last Accessed Date: 2020 19-2-2020. Available from: https://www.bapen.org.uk/screening-and-must/ must-calculator
  • 4. Stratton RJ, Hackston A, Longmore D, et al. Malnutrition in hospital outpatients and inpatients: prevalence, concurrent validity and ease of use of the ‘malnutrition universal screening tool’ (‘MUST’) for adults. Br J Nutr 2004;92:799-808.
  • 5. Vellas B, Guigoz Y, Garry PJ, et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 1999;15:116-122.
  • 6. Kondrup J, Rasmussen HH, Hamberg O, Stanga Z, Ad Hoc EWG. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 2003;22:321-336.
  • 7. Kondrup J, Allison SP, Elia M, et al. ESPEN guidelines for nutrition screening 2002. Clin Nutr 2003;22:415-421.
  • 8. Mueller C, Compher C, Ellen DM, American Society for P, Enteral Nutrition Board of D. A.S.P.E.N. clinical guidelines: nutrition screening, assessment, and intervention in adults. JPEN J Parenter Enteral Nutr 2011;35:16-24.
  • 9. Weekes CE, Elia M, Emery PW. The development, validation and reliability of a nutrition screening tool based on the recommendations of the British Association for Parenteral and Enteral Nutrition (BAPEN). Clin Nutr 2004;23:1104-1112.
  • 10. Cederholm T, Jensen GL, Correia M, et al. GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community. Clin Nutr 2019;38:1-9.
  • 11. Gomes F, Schuetz P, Bounoure L, et al. ESPEN guidelines on nutritional support for polymorbid internal medicine patients. Clin Nutr 2018;37:336- 353.
  • 12. Volkert D, Beck AM, Cederholm T, et al. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin Nutr 2019;38:10-47.
  • 13. Milne AC, Avenell A, Potter J. Oral protein and energy supplementation in older people: a systematic review of randomized trials. Nestle Nutr Workshop Ser Clin Perform Programme 2005;10:103-125.
  • 14. Milne AC, Avenell A, Potter J. Meta-analysis: protein and energy supplementation in older people. Ann Intern Med 2006;144:37-48.
  • 15. Milne AC, Potter J, Avenell A. Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev 2002;CD003288.
  • 16. Milne AC, Potter J, Vivanti A, Avenell A. Protein and energy supple mentation in elderly people at risk from malnutrition. Cochrane Database Syst Rev 2009:CD003288.
  • 17. Deutz NE, Matheson EM, Matarese LE, et al. Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: a randomized clinical trial. Clin Nutr 2016;35:18- 26.
  • 18. Schuetz P, Fehr R, Baechli V, et al. Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial. Lancet 2019;393:2312-2321.
  • 19. Allen VJ, Methven L, Gosney MA. Use of nutritional complete supplements in older adults with dementia: systematic review and meta-analysis of clinical outcomes. Clin Nutr 2013;32:950-957.
  • 20. Tangvik RJ, Bruvik FK, Drageset J, Kyte K, Hunskar I. Effects of oral nutrition supplements in persons with dementia: a systematic review. Geriatr Nurs 2020;42:117-123.
  • 21. Hines S, Wilson J, McCrow J, Abbey J, Sacre S. Oral liquid nutritional supplements for people with dementia in residential aged care facilities. Int J Evid Based Healthc 2010;8:248-251.
  • 22. Volkert D, Chourdakis M, Faxen-Irving G, et al. ESPEN guidelines on nutrition in dementia. Clin Nutr 2015;34:1052-1073.
  • 23. Silva LB, Mourao LF, Silva AA, et al. Effect of nutritional supplementation with milk whey proteins in amyotrophic lateral sclerosis patients. Arq Neuropsiquiatr 2010;68:263-268.
  • 24. Dennis M, Lewis S, Cranswick G, Forbes J, Collaboration FT. FOOD: a multicentre randomised trial evaluating feeding policies in patients admitted to hospital with a recent stroke. Health Technol Assess 2006;10:iii-iv, ix-x, 1-120.
  • 25. Geeganage C, Beavan J, Ellender S, Bath PM. Interventions for dysphagia and nutritional support in acute and subacute stroke. Cochrane Database Syst Rev 2012;10:CD000323.
  • 26. Gariballa SE, Parker SG, Taub N, Castleden CM. A randomized, controlled, a single-blind trial of nutritional supplementation after acute stroke. JPEN J Parenter Enteral Nutr 1998;22:315-319.
  • 27. Rabadi MH, Coar PL, Lukin M, Lesser M, Blass JP. Intensive nutritional supplements can improve outcomes in stroke rehabilitation. Neurology 2008;71:1856-1861.
  • 28. Sakai K, Kinoshita S, Tsuboi M, et al. Effects of nutrition therapy in older stroke patients undergoing rehabilitation: a systematic review and metaanalysis. J Nutr Health Aging 2019;23:21-26.
  • 29. van der Marck MA, Dicke HC, Uc EY, et al. Body mass index in Parkinson’s disease: a meta-analysis. Parkinsonism Relat Disord 2012;18:263-267.
  • 30. Wang YL, Wang YT, Li JF, et al. Body mass index and risk of Parkinson’s disease: a dose-response meta-analysis of prospective studies. PLoS One 2015;10:e0131778.
  • 31. Tosukhowong P, Boonla C, Dissayabutra T, et al. Biochemical and clinical effects of Whey protein supplementation in Parkinson’s disease: a pilot study. J Neurol Sci 2016;367:162-170.
  • 32. Barichella M, Cereda E, Pinelli G, et al. Muscle-targeted nutritional support for rehabilitation in patients with parkinsonian syndrome. Neurology 2019;93:e485-e496. doi: 10.1212/WNL.0000000000007858. Epub 2019 Jul 5.
  • 33. Redondo Robles L, Pintor de la Maza B, Tejada Garcia J, et al. Nutritional profile of multiple sclerosis. Nutr Hosp 2019;36:340-349.
  • 34. Beaudart C, Sanchez-Rodriguez D, Locquet M, et al. Malnutrition as a Strong Predictor of the Onset of Sarcopenia. Nutrients 2019;11:2883.
  • 35. Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet 2019;393:2636-2646.
  • 36. Guidelines for Prescribing Oral Nutritional Supplements in Adults Last Accessed Date: 02.02.2020. Available from: https://www.nottsapc.nhs.uk/ media/1111/sip-feeds-full-guideline.pdf
  • 37. A Guide to Managing Adult Malnutrition in the Community including a pathway for the appropriate use of Oral Nutritional Supplements (ONS). Last Accessed Date: 02.02.2020. Available from: https://www. malnutritionpathway.co.uk/library/managing_malnutrition.pdf
  • 38. Food First/Food Enrichment. Last Accessed Date: 18.02.2020. Available from: https://www.bapen.org.uk/nutrition-support/nutrition-by-mouth/ food-first-food-enrichment
  • 39. Morilla-Herrera JC, Martin-Santos FJ, Caro-Bautista J, et al. Effectiveness of food-based fortification in older people. a systematic review and metaanalysis. J Nutr Health Aging 2016;20:178-184.
  • 40. Baldwin C, Kimber KL, Gibbs M, Weekes CE. Supportive interventions for enhancing dietary intake in malnourished or nutritionally at-risk adults. Cochrane Database Syst Rev 2016;12:CD009840.
  • 41. Mills SR, Wilcox CR, Ibrahim K, Roberts HC. Can fortified foods and snacks increase the energy and protein intake of hospitalised older patients? A systematic review. J Hum Nutr Diet 2018;31:379-389.
  • 42. Baldwin C, Weekes CE. Dietary advice with or without oral nutritional supplements for disease-related malnutrition in adults. Cochrane Database Syst Rev 2011:CD002008.
  • 43. Trabal J, Farran-Codina A. Effects of dietary enrichment with conventional foods on energy and protein intake in older adults: a systematic review. Nutr Rev 2015;73:624-633.
  • 44. No Author Listed. What role for oral nutritional supplements in primary care? Drug Ther Bull 2018;56:90-93.
  • 45. Hubbard GP, Elia M, Holdoway A, Stratton RJ. A systematic review of compliance to oral nutritional supplements. Clin Nutr 2012;31:293-312.
  • 46. Ludolph AC, Dorst J, Dreyhaupt J, et al. Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis. Ann Neurol 2020;87:206-216.
  • 47. Dorst J, Cypionka J, Ludolph AC. High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: a prospective interventional study. Amyotroph Lateral Scler Frontotemporal Degener 2013;14:533-536.
  • 48. Andersen PM, Abrahams S, Borasio GD, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force. Eur J Neurol 2012;19:360-375.
  • 49. Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009;73:1218-1226.
  • 50. Cereda E, Barichella M, Pedrolli C, Pezzoli G. Low-protein and proteinredistribution diets for Parkinson’s disease patients with motor fluctuations: a systematic review. Mov Disord 2010;25:2021-2034.
  • 51. Wang L, Xiong N, Huang J, et al. Protein-restricted diets for ameliorating motor fluctuations in Parkinson’s disease. Front Aging Neurosci 2017;9:206.
  • 52. Virmani T, Tazan S, Mazzoni P, Ford B, Greene PE. Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson’s disease. J Clin Mov Disord 2016;3:8.
  • 53. McKendry J, Currier BS, Lim C, et al. Nutritional supplements to support resistance exercise in countering the sarcopenia of aging. Nutrients 2021;12:2057.
  • 54. Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc 2013;14:542-559.
  • 55. Bear DE, Cruz-Jentoft AJ, Stout JR. beta-hydroxy-beta-methylbutyrate supplementation in older persons - an update. Curr Opin Clin Nutr Metab Care 2021;24:48-52.
  • 56. Elia M, Normand C, Norman K, Laviano A. A systematic review of the cost and cost effectiveness of using standard oral nutritional supplements in the hospital setting. Clin Nutr 2016;35:370-380.
  • 57. Elia M, Normand C, Laviano A, Norman K. A systematic review of the cost and cost effectiveness of using standard oral nutritional supplements in community and care home settings. Clin Nutr 2016;35:125-137.
  • 58. Hugo C, Isenring E, Miller M, Marshall S. Cost-effectiveness of food, supplement and environmental interventions to address malnutrition in residential aged care: a systematic review. Age Ageing 2018;47:356-366.
  • 59. Correa-Perez A, Abraha I, Cherubini A, et al. Efficacy of non-pharmacological interventions to treat malnutrition in older persons: A systematic review and meta-analysis. The SENATOR project ONTOP series and MaNuEL knowledge hub project. Ageing Res Rev 2019;49:27-48.
APA TOPCUOGLU M, Arsava E, Saka Topçuoğlu E (2021). Use of Oral Nutritional Supplements in Neurology: General Principles, Special Practices. , 102 - 110. 10.4274/tnd.2021.53503
Chicago TOPCUOGLU MEHMET,Arsava Ethem Murat,Saka Topçuoğlu Esen Use of Oral Nutritional Supplements in Neurology: General Principles, Special Practices. (2021): 102 - 110. 10.4274/tnd.2021.53503
MLA TOPCUOGLU MEHMET,Arsava Ethem Murat,Saka Topçuoğlu Esen Use of Oral Nutritional Supplements in Neurology: General Principles, Special Practices. , 2021, ss.102 - 110. 10.4274/tnd.2021.53503
AMA TOPCUOGLU M,Arsava E,Saka Topçuoğlu E Use of Oral Nutritional Supplements in Neurology: General Principles, Special Practices. . 2021; 102 - 110. 10.4274/tnd.2021.53503
Vancouver TOPCUOGLU M,Arsava E,Saka Topçuoğlu E Use of Oral Nutritional Supplements in Neurology: General Principles, Special Practices. . 2021; 102 - 110. 10.4274/tnd.2021.53503
IEEE TOPCUOGLU M,Arsava E,Saka Topçuoğlu E "Use of Oral Nutritional Supplements in Neurology: General Principles, Special Practices." , ss.102 - 110, 2021. 10.4274/tnd.2021.53503
ISNAD TOPCUOGLU, MEHMET vd. "Use of Oral Nutritional Supplements in Neurology: General Principles, Special Practices". (2021), 102-110. https://doi.org/10.4274/tnd.2021.53503
APA TOPCUOGLU M, Arsava E, Saka Topçuoğlu E (2021). Use of Oral Nutritional Supplements in Neurology: General Principles, Special Practices. Türk Nöroloji Dergisi, 27(2), 102 - 110. 10.4274/tnd.2021.53503
Chicago TOPCUOGLU MEHMET,Arsava Ethem Murat,Saka Topçuoğlu Esen Use of Oral Nutritional Supplements in Neurology: General Principles, Special Practices. Türk Nöroloji Dergisi 27, no.2 (2021): 102 - 110. 10.4274/tnd.2021.53503
MLA TOPCUOGLU MEHMET,Arsava Ethem Murat,Saka Topçuoğlu Esen Use of Oral Nutritional Supplements in Neurology: General Principles, Special Practices. Türk Nöroloji Dergisi, vol.27, no.2, 2021, ss.102 - 110. 10.4274/tnd.2021.53503
AMA TOPCUOGLU M,Arsava E,Saka Topçuoğlu E Use of Oral Nutritional Supplements in Neurology: General Principles, Special Practices. Türk Nöroloji Dergisi. 2021; 27(2): 102 - 110. 10.4274/tnd.2021.53503
Vancouver TOPCUOGLU M,Arsava E,Saka Topçuoğlu E Use of Oral Nutritional Supplements in Neurology: General Principles, Special Practices. Türk Nöroloji Dergisi. 2021; 27(2): 102 - 110. 10.4274/tnd.2021.53503
IEEE TOPCUOGLU M,Arsava E,Saka Topçuoğlu E "Use of Oral Nutritional Supplements in Neurology: General Principles, Special Practices." Türk Nöroloji Dergisi, 27, ss.102 - 110, 2021. 10.4274/tnd.2021.53503
ISNAD TOPCUOGLU, MEHMET vd. "Use of Oral Nutritional Supplements in Neurology: General Principles, Special Practices". Türk Nöroloji Dergisi 27/2 (2021), 102-110. https://doi.org/10.4274/tnd.2021.53503